Labelling of mammalian cells for visualisation by MRI

被引：25

作者：

Bernsen, Monique R. ^{[1
,2
]}

Moelker, Amber D. ^{[2
]}

Wielopolski, Piotr A. ^{[2
]}

van Tiel, Sandra T. ^{[2
]}

Krestin, Gabriel P. ^{[2
]}

机构：

[1] Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands

[2] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, NL-3015 GE Rotterdam, Netherlands

来源：

EUROPEAN RADIOLOGY | 2010年 / 20卷 / 02期

关键词：

Cell labelling; Contrast agents; Cell tracking; Apoptosis; MRI; MESENCHYMAL STEM-CELLS; IRON-OXIDE PARTICLES; MAGNETIC-RESONANCE TRACKING; IN-VIVO TRACKING; HEMATOPOIETIC PROGENITOR CELLS; CONTRAST AGENTS; BONE-MARROW; TAT PEPTIDE; T-CELLS; TRANSFECTION AGENT;

D O I：

10.1007/s00330-009-1540-1

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Through labelling of cells with magnetic contrast agents it is possible to follow the fate of transplanted cells in vivo with magnetic resonance imaging (MRI) as has been demonstrated in animal studies as well as in a clinical setting. A large variety of labelling strategies are available that allow for prolonged and sensitive detection of the labelled cells with MRI. The various protocols each harbour specific advantages and disadvantages. In choosing a particular labelling strategy it is also important to ascertain that the labelling procedure does not negatively influence cell functionality, for which a large variety of assays are available. In order to overcome the challenges still faced in fully exploiting the benefits of in vivo cell tracking by MRI a good understanding and standardisation of the procedures and assays used will be crucial.

引用

页码：255 / 274

页数：20

共 186 条

[1]

Abou-Montet K, 2005, MOL IMAGING, V4, P165

[2] In vivo imaging platform for tracking immunotherapeutic cells [J].

Ahrens, ET ;

Flores, R ;

Xu, HY ;

Morel, PA .

NATURE BIOTECHNOLOGY, 2005, 23 (08) :983-987

[3] Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging [J].

Ahrens, ET ;

Feili-Hariri, M ;

Xu, H ;

Genove, G ;

Morel, PA .

MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (06) :1006-1013

[4] Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates [J].

Aime, S ;

Barge, A ;

Cabella, C ;

Crich, SG ;

Gianolio, E .

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (06) :509-518

[5] Tunable imaging of cells labeled with MRI-PARACEST agents [J].

Aime, S ;

Carrera, C ;

Delli Castelli, D ;

Crich, SG ;

Terreno, E .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (12) :1813-1815

[6] Noninvasive imaging of cell-mediated therapy for treatment of cancer [J].

Akins, Elizabeth J. ;

Dubey, Purnima .

JOURNAL OF NUCLEAR MEDICINE, 2008, 49 :180S-195S

[7] Iron-oxide Labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium [J].

Amsalem, Yoram ;

Mardor, Yael ;

Feinberg, Micha S. ;

Landa, Natalie ;

Miller, Liron ;

Daniels, Dianne ;

Ocherashvilli, Aharon ;

Holbova, Radka ;

Yosef, Orna ;

Barbash, Israel M. ;

Leor, Jonathan .

CIRCULATION, 2007, 116 (11) :I38-I45

[8] Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging [J].

Anderson, SA ;

Lee, KK ;

Frank, JA .

INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :332-338

[9] Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model [J].

Anderson, SA ;

Glod, J ;

Arbab, AS ;

Noel, M ;

Ashari, P ;

Fine, HA ;

Frank, JA .

BLOOD, 2005, 105 (01) :420-425

[10] Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride [J].

Aoki, I ;

Yoshiyuki, T ;

Chuang, KH ;

Silva, AC ;

Igarashi, T ;

Tanaka, C ;

Childs, RW ;

Koretsky, AP .

NMR IN BIOMEDICINE, 2006, 19 (01) :50-59

← 1 2 3 4 5 6 7 8 9 10 →